TAO2 Activators
Serine/threonine-protein kinase TAO2 activators encompass a diverse class of chemical compounds that indirectly influence the activity of TAO2 through modulation of various signaling pathways. These activators do not directly bind or alter the TAO2 protein itself but instead affect the cellular signaling milieu in which TAO2 operates. The majority of these activators interact with the MAPK signaling cascade, a pathway where TAO2 has a role. The compounds range from small molecule inhibitors to natural products, and their primary functions vary from modulating enzymatic activities in the pathway to affecting transcriptional responses that would alter the pathway's activity and hence TAO2's role within it.
Within this class, one can find compounds that act on different components of the MAPK pathway such as MEK and JNK inhibitors or adenylate cyclase activators, which in turn could affect TAO2 indirectly. By inhibiting or altering the function of kinases that are upstream or downstream of TAO2, these compounds can cause changes in the phosphorylation state and activity of the TAO2 kinase. Additionally, some of these chemicals interact with parallel signaling pathways, such as the PI3K/AKT pathway or the mTOR signaling pathway, creating a ripple effect that can extend to the MAPK pathway and thus modulate TAO2 activity. The effects of these compounds on TAO2 activity are context-dependent and may vary based on the cell type, the state of cellular differentiation, and the presence of other signaling molecules.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an analog of adenosine monophosphate (AMP) that can activate AMP-activated protein kinase (AMPK). Activation of AMPK has been shown to modulate the p38 MAPK pathway, which is a pathway TAO2 is known to interact with, thus indirectly affecting TAO2 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to increased levels of cyclic AMP (cAMP) and activation of cAMP-dependent protein kinase A (PKA). PKA can phosphorylate various proteins in the MAPK pathway, which is associated with TAO2 signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences the phosphoinositide pathway by inhibiting inositol monophosphatase, which could lead to alterations in signaling pathways, including those involving TAO2, although the exact mechanism of how this influences TAO2 activity is not fully elucidated. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound is a p38 MAPK inhibitor that can affect the feedback loops within the p38 MAPK signaling cascade. TAO2 can phosphorylate and activate the p38 MAPK; thus, modulating this pathway can indirectly affect the activity levels of TAO2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is involved in the MAPK signaling pathway. TAO2 has been implicated in the MAPK pathway, indicating that JNK modulation may also influence TAO2 activity by altering stress response signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that impacts the MAPK/ERK pathway. Since TAO2 can affect MAPK pathway components, this inhibitor may alter the cellular context in which TAO2 operates, indirectly affecting its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to changes in AKT signaling, which has been associated with the regulation of MAPK pathways. TAO2 interacts with components of the MAPK signaling pathway, which could be influenced by PI3K/AKT modulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a central regulator of cell growth and survival, and this can lead to changes in MAPK pathway activity. TAO2 may thus be indirectly affected due to alterations in cellular growth signals. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects multiple signaling pathways including the MAPK pathway, which is linked to TAO2 function. By modulating this pathway, curcumin can have an indirect effect on the activity of TAO2. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is involved in the activation of SIRT1, which can deacetylate proteins involved in the MAPK pathway. As TAO2 is associated with the MAPK signaling pathway, this suggests that resveratrol could influence TAO2 activity indirectly. | ||||||